1289862

Vemulkonda K. Rao, M.D. — FEI 3023709962

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 29, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bethesda, MD (United States)

Additional Details

Clinical BA/BE

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance